Trial: 202001168

A Phase 2, Single-Arm Open-Label Study of Abemaciclib for Treatment of Advanced Bone and Soft Tissue Sarcoma Identified as having CDK Pathway Alteration

Phase

II

Principal Investigator

Weiss, Mia

Disease Site

Bones and Joints; Soft Tissue

Learn more about this study at: clinicaltrials.gov